Get the Stockscreener App
1.41
5.37%
-0.08
After Hours:
1.45
0.04
+2.84%
Intelligent Bio Solutions Inc stock is traded at $1.41, with a volume of 82,299.
It is down -5.37% in the last 24 hours and up +13.71% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
See More
Previous Close:
$1.49
Open:
$1.49
24h Volume:
82,299
Relative Volume:
0.74
Market Cap:
$9.74M
Revenue:
$3.19M
Net Income/Loss:
$-10.42M
P/E Ratio:
-0.0397
EPS:
-35.4757
Net Cash Flow:
$-10.65M
1W Performance:
+0.00%
1M Performance:
+13.71%
6M Performance:
-11.88%
1Y Performance:
-41.74%
1-Day Range:
$1.40
$1.4982
1-Week Range:
$1.38
$1.57
52-Week Range:
$1.00
$3.00
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-233-6971
Address
135 W 41ST ST,, NEW YORK
Compare INBS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.41 | 9.74M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows - Yahoo Finance
Healthcare's Quiet AI Boom Is Creating a New Class of Breakout Contenders - The Globe and Mail
Intelligent Bio Solutions Advances Innovative Fingerprint Drug Testing Technology Toward U.S. Market - citybuzz -
Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference - Yahoo Finance
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing a - GuruFocus
Intelligent Bio Solutions (INBS) to Showcase Drug Testing System at RISE25 | INBS Stock News - GuruFocus
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing - The Manila Times
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing | INBS Stock News - GuruFocus
Intelligent Bio Solutions Inc. to Showcase Drug Testing Innovation at RISE25 Conference with Partner SMARTOX - Nasdaq
Intelligent Bio Solutions Expands Global Reach with Multilingual Digital Strategy - citybuzz -
INBS Expands Workforce Drug Testing with Successful Remote Opera - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Tes - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment | INBS Stock News - GuruFocus
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment - The Manila Times
Intelligent Bio Solutions Inc. Successfully Conducts High-Volume Workforce Drug Testing for Barcaldine Regional Council in Queensland, Australia - Nasdaq
4 Top Cybersecurity Stocks to Buy in May - The Globe and Mail
Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally - The Globe and Mail
Intelligent Bio Solutions Expands Global Operations - TipRanks
Intelligent Bio Solutions (INBS) Achieves Significant Growth wit - GuruFocus
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally - Yahoo Finance
Intelligent Bio Solutions (INBS) Achieves Significant Growth with New Accounts and Technology | INBS Stock News - GuruFocus
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing - The Manila Times
Intelligent Bio Solutions Inc. Reports Significant Growth Across Global Operations with Over 450 Active Accounts and Expansion into New Sectors - Nasdaq
Fingerprint Drug Testing Revolution: How Intelligent Bio Solutions Captured 450+ Global Accounts in 24 Countries - Stock Titan
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Res - GuruFocus
Intelligent Bio Solutions Reports Strong Q3 2025 Results - TipRanks
IBN Coverage: Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins - Yahoo Finance
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements - ADVFN
Intelligent Bio Solutions (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins - Barchart.com
Intelligent Bio Solutions (INBS) Sees Revenue Dip but Focuses on Strategic Growth | INBS Stock News - GuruFocus
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91% - Benzinga
Intelligent Bio Solutions (NASDAQ: INBS) Is ‘One to Watch’ - The Globe and Mail
Intelligent Bio Solutions (NASDAQ: INBS) Is ‘One To Watch’ - Barchart.com
Intelligent Bio Solutions (INBS) Expands Global Presence with Ne - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion | INBS Stock News - GuruFocus
Intelligent Bio Solutions (INBS) Expands Global Presence with New Websites | INBS Stock News - GuruFocus
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion - The Manila Times
Intelligent Bio Solutions Targets $1.1B Market with Global Drug Testing Expansion in Arabic, Spanish Markets - Stock Titan
Texas Capital Bancshares, Inc. (NASDAQ:TCBI) Given Average Rating of “Hold” by Analysts - American Banking and Market News
Intelligent Bio Solutions Adds Latin American Spanish To Drug Screening System To Expand Reach - Nasdaq
Intelligent Bio Solutions (INBS) Expands Language Options in Dru - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - The Manila Times
Intelligent Bio Solutions Expands Drug Screening Reach: Eyes Massive $1.1B Latin American Market Opportunity - Stock Titan
XTX Topco Ltd Buys New Position in Credit Acceptance Co. (NASDAQ:CACC) - American Banking and Market News
Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 MillionSEC Filing - MarketScreener
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - The Globe and Mail
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):